Statement on Brexit by the Wellcome Sanger Institute, the European Molecular Biology Laboratory (EMBL) and the Francis Crick Institute

Statement on Brexit by the Wellcome Sanger Institute, the European Molecular Biology Laboratory (EMBL) and the Francis Crick Institute

Today marks the next chapter in the UK’s relationship with Europe. While we wait to see what a future relationship brings, researchers will continue to work across borders to tackle society’s most pressing problems, such as climate change, ageing and disease.

Science thrives when it has no boundaries and the Francis Crick Institute, the European Molecular Biology Laboratory (EMBL) and the Wellcome Sanger Institute are defined by our diversity and international nature.

One of EMBL’s six sites – the European Bioinformatics Institute - is located in the UK at the Wellcome Genome Campus, alongside the Sanger Institute.

All three institutions bring people together from diverse backgrounds, often across borders. This enhances science and will drive the continued success of research in the UK and Europe.

Whatever the outcome of Brexit, we will remain open and welcoming to scientists and students from around the world.

We all benefit from these collaborations, not just scientists. As we continue to work together across Europe, we can deliver greater benefits for people around the world.

Professor Sir Mike Stratton
Director
Wellcome Sanger Institute

Professor Edith Heard
Director General
European Molecular Biology Laboratory (EMBL)

Professor Sir Paul Nurse
Director
Francis Crick Institute



 

Notes to Editors
Contact the Press Office

Emily Mobley, Media Manager

Tel +44 (0)1223 496 851

Dr Samantha Wynne, Media Officer

Tel +44 (0)1223 492 368

Dr Matthew Midgley, Media Officer

Tel +44 (0)1223 494 856

Wellcome Sanger Institute,
Hinxton,
Cambridgeshire,
CB10 1SA,
UK

Mobile +44 (0)7900 607793

Recent News

UK launches whole genome sequence alliance to map spread of coronavirus
The Wellcome Sanger Institute will collaborate with expert groups across the country to analyse the genetic code of COVID-19 samples circulating in the UK, providing public health agencies with a unique tool to combat the virus
Sanger Institute scientist wins 2021 Biochemical Society award
Roser Vento-Tormo awarded an Early Career Research Award
Sanger Institute and Wellcome Genome Campus temporarily closed to all but critical research
In response to the rapidly changing COVID-19 pandemic, the Sanger Institute and its neighbours on the Wellcome Genome Campus will close all but critical and essential operations from Friday 20 March.